Jan 13 (Reuters) - Salarius Pharmaceuticals Inc ( SLRX ) : * SALARIUS PHARMACEUTICALS AND DECOY THERAPEUTICS ANNOUNCE DEFINITIVE MERGER AGREEMENT * SALARIUS PHARMACEUTICALS INC ( SLRX ) - NEWLY FORMED COMPANY TO BE NAMED DECOY THERAPEUTICS * SALARIUS PHARMACEUTICALS INC ( SLRX ) - COMBINED COMPANY TO BE LED BY DECOY'S CO-FOUNDERS * SALARIUS PHARMACEUTICALS INC ( SLRX )...

Jan 13 (Reuters) - Eli Lilly ( LLY ) said on Monday it would buy cancer therapy developer Scorpion Therapeutics for up to $2.5 billion in cash. Lilly will acquire Scorpion's experimental oral therapy, STX-478, which is currently being tested in early-stage trials for breast cancer and other advanced solid tumors. The therapy is a PI3K inhibitor, which selectively targets...

09:35 AM EST, 01/13/2025 (MT Newswires) -- Apple's ( AAPL ) new fees for app developers are under scrutiny from EU competition watchdogs amid concerns they may increase costs for software makers, Bloomberg reported Monday, quoting unnamed sources. European Commission regulators sent questionnaires to app developers in December centered on Apple's ( AAPL ) core technology fee, which is a...

NEW YORK (Reuters) - Proxy advisory firm Institutional Shareholder Services on Monday recommended that Air Products and Chemicals ( APD ) investors elect three of activist investor Mantle Ridge's four director candidates. The recommendation comes days after another proxy advisory firm, Glass Lewis, said investors should elect all four of the dissident's nominees at the January 23 annual meeting. ISS...